Your institution may have access to this item. Find your institution then sign in to continue.
Title
Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.
Authors
Gray, Shelly L; LaCroix, Andrea Z; Larson, Joseph; Robbins, John; Cauley, Jane A; Manson, JoAnn E; Chen, Zhao
Abstract
Proton pump inhibitor (PPI) medications have been inconsistently shown to be associated with osteoporotic fractures. We examined the association of PPI use with bone outcomes (fracture, bone mineral density [BMD]).
Publication
Archives of internal medicine, 2010, Vol 170, Issue 9, p765